Search results
Author(s):
John R Teerlink
Added:
3 years ago
Pulmonary arterial hypertension (PAH) is a progressive and debilitating disease with limited treatment options. Although some patients do well with calcium channel blockers, most ultimately need more advanced therapy, such as prostanoids. Recently, a new class of therapeutic agents has been developed to treat these patients: the endothelin receptor antagonists (ERAs). Although they are not…
View more
Author(s):
Kathy Glatter
Added:
3 years ago
Introduction
Strictly speaking, there are no arrhythmias that are specific to women. However, as with most diseases, the diagnosis of arrhythmias presents unique challenges when applied to women. Women have distinct symptoms, different etiologies and incidences of arrhythmias, and even differing outcomes compared with men.
This article will discuss both the benign and more malignant arrhythmias…
View more
Author(s):
John R Teerlink
Added:
3 years ago
Pulmonary arterial hypertension (PAH) is a progressive and debilitating disease with limited treatment options. Although some patients do well with calcium channel blockers, most ultimately need more advanced therapy, such as prostanoids. Recently, a new class of therapeutic agents has been developed to treat these patients: the endothelin receptor antagonists (ERAs). Although they are not…
View more
Author(s):
Kathy Glatter
Added:
3 years ago
Introduction
Strictly speaking, there are no arrhythmias that are specific to women. However, as with most diseases, the diagnosis of arrhythmias presents unique challenges when applied to women. Women have distinct symptoms, different etiologies and incidences of arrhythmias, and even differing outcomes compared with men.
This article will discuss both the benign and more malignant arrhythmias…
View more
Author(s):
Denton A Cooley
Added:
3 years ago
Innovative technologies and refinements of existing therapies are shaping 21st century cardiovascular diagnosis and treatment. Researchers are gaining new perspectives on diseases and their treatment at the cellular and subcellular levels. Cardiologists are evaluating and treating coronary arteries by means of intravascular intervention. Surgeons are shortening recovery times and increasing cost…
View more
Author(s):
Nithima Chaowalit
,
Patricia A Pellikka
Added:
3 years ago
How Far Have We Come?
Cardiac imaging using ultrasound (so-called ‘echocardiography’) was introduced more than 50 years ago. Resting echocardiographic detection of myocardial infarction was described as the reduction in regional contractile function,1 and the development of stress echocardiography in the early era was recognised after the introduction of 2D echocardiographic imaging. The initial…
View more
Author(s):
Robert Hebeler
Added:
3 years ago
Since its introduction in 1987, the Maze procedure has been regarded as the 'gold standardÔÇÖ for the surgical treatment of atrial fibrillation (AF). However, the complexity of the procedure has restricted its adoptability in the surgical community and provided an impetus for the development of less complex operations for the effective treatment of AF. The absolute number of patients who have…
View more
Author(s):
Marc Sirol
Added:
3 years ago
Atherosclerosis and its thrombotic complications are the first cause of mortality and morbidity in industrialized countries. Furthermore, despite pharmacological intervention and lifestyle changes, cardiovascular disease (CVD) continues to be the principal cause of death in the US. Despite great advances in the understanding of the initiation and progression of atherosclerosis and its risk…
View more
Added:
2 years ago
Source:
EchoNous
A portable heart scanner which uses breakthrough artificial intelligence is solving reproducibility and repeatability issues in echocardiography, enabling clinicians to diagnose heart failure more quickly whilst also shortening exam times.
Renowned cardiologists say that as well as helping to save time - enabling them to see more patients and reducing waiting times - it tackles the long…
View more
Author(s):
Robert Hebeler
Added:
3 years ago
Since its introduction in 1987, the Maze procedure has been regarded as the 'gold standardÔÇÖ for the surgical treatment of atrial fibrillation (AF). However, the complexity of the procedure has restricted its adoptability in the surgical community and provided an impetus for the development of less complex operations for the effective treatment of AF. As Dr James Cox has noted, the absolute…
View more